Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]

Read More

No American Has Ever Said, “I Regret Refusing the Covid Vaccine.” So, Here are Three Simple, Easy, Reasonable, Moderate Steps President Trump Can Take to Keep Us Safe.

by Assistant Editor GWP, Wayne Allyn Root Look around. No one wants the latest Covid-19 booster. Do you know why? It’s the dirtiest secret in America. The mainstream media won’t tell you…[...]

Read More

Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy

Baneet Kaur • Cyril Blavo • Mayur S. Parmar, DOI: 10.7759/cureus.56025  Abstract Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. Ivermectin has become a versatile…[...]

Read More

Effects of Non-invasive Vagus Nerve Stimulation on Inflammatory Markers in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amira Mohamed Taha • Amr Elrosasy • Ahmed S. Mohamed •et.al. DOI: 10.7759/cureus.70613  Abstract The international healthcare community has encountered several difficulties because of the COVID-19 pandemic brought on by SARS-CoV-2. COVID-19 can lead to an…[...]

Read More